MannKind Corp Sustainability Reports
MannKind Corporation specializes in the development and commercialization of therapeutic products for the treatment of diabetes and related health conditions.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US56400P7069
24 reports from 2004 to 2025